VIRVir Biotechnology, Inc.

$11.10

Who owns VIR

248 institutions reported holding VIR for 2026Q1, together 95% of the company, more than the 216 a quarter earlier.

248

Institutions reporting a position · as of 2026Q1 · up from 216 the quarter before

Shares held by institutions
139.5M

Shares held by institutions · 95% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.25B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
45%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
26
New positions
61
Positions exited
35
Added to
113
Reduced
39
Top 10 holdersof the company
57%
Institutional ownership by quarter, 2019Q4 to 2026Q1
QuarterFilersSharesReported value
2026Q1248139.5M$1.25B
2025Q4216115.5M$696M
2025Q3211107.0M$611M
2025Q2211110.8M$558M
2025Q123193.3M$604M
2024Q420688.8M$652M
2024Q319687.6M$656M
2024Q221388.0M$783M
2024Q120788.9M$901M
2023Q420588.2M$887M
2023Q321188.3M$827M
2023Q222490.8M$2.23B
2023Q122988.4M$2.05B
2022Q422486.1M$2.18B
2022Q322086.9M$1.68B
2022Q221085.8M$2.19B
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.18.0M12%$161M
VANGUARD GROUP INC15.5M11%$139M
ARCH Venture Management, LLC12.9M8.8%$116M
SB INVESTMENT ADVISERS (UK) LTD10.9M7.4%$98M
GSK plc8.6M5.8%$77M
STATE STREET CORP7.1M4.8%$64M
GOLDMAN SACHS GROUP INC3.3M2.2%$29M
MORGAN STANLEY2.9M1.9%$26M
ADAR1 Capital Management, LLC2.7M1.9%$25M
GEODE CAPITAL MANAGEMENT LLC2.7M1.8%$24M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…